Lane 1: human brain lysate; Lane 2: human cerebellum lysate at 20 µg per lane, probed with bsm-51047M GFAP (183CT3.1.5) Monoclonal Antibody at 1:4000 dilution and 4℃ overnight incubation, followed by secondary antibody incubation for 60min at room temperature.
Lane 1: human brain lysate; Lane 2: human cerebellum lysate at 20 µg per lane, probed with bsm-51047M GFAP (183CT3.1.5) Monoclonal Antibody at 1:4000 dilution and 4℃ overnight incubation, followed by secondary antibody incubation for 60min at room temperature.
GFAP (3C5) Monoclonal Antibody
BSM-51047M
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman, Rat
TargetGFAP
Overview
- SupplierBioss Antibodies
- Product NameGFAP (3C5) Monoclonal Antibody
- Delivery Days Customer16
- ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), IHC-P(1:200-400)
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone ID3C5
- Concentration0.5 ug/ml
- ConjugateUnconjugated
- Gene ID2670
- Target nameGFAP
- Target descriptionglial fibrillary acidic protein
- Target synonymsALXDRD; glial fibrillary acidic protein
- HostMouse
- IsotypeIgG2b
- Protein IDP14136
- Protein NameGlial fibrillary acidic protein
- ReactivityHuman, Rat
- Storage Instruction-20°C
- UNSPSC12352203
References
- Melatonin lowers edema after spinal cord injury. Li C et al., 2014 Dec 15, Neural Regen ResRead more